spermatogonia divide once more to produce groups of four type A al spermatogonia, also connected to one another. The A al cells proliferate resulting in chains of 8, 16 , and occasionally 32 cells. Most of the A al spermatogonia undergo a morphological change and transform into type A 1 spermatogonia. These A 1 spermatogonia are the first generation of differentiating A and B spermatogonia (►Fig. 1).
However, a revision of this A s model might be necessary. Recently, several research groups found that the A s population and spermatogonial chains of the same length are heterogeneous in respect to their gene expression [15] [16] [17] (►Fig. 2).
Using the transplantation assay developed by the Brinster group, 18, 19 it was possible to demonstrate that stem cell activity is limited to the undifferentiated spermatogonia A s , A pr , and A al . 20, 21 Differentiating spermatogonia have a weaker potential to self-renew.
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In primates, two morphologically different classes of type A spermatogonia are observed: the dark A d (or "reserve" stem cells) and the pale A p spermatogonia (or "renewing" stem cells). 
Spermatogonial Stem Cell Identity
Spermatogonia are small single cells located on the basement membrane of the seminiferous tubules. They have an ovoid nucleus with the nucleoli close to the nuclear membrane. The dense cytoplasm contains a small Golgi apparatus, few mitochondria, and many free ribosomes. The SSC population is only a very small subpopulation of the spermatogonia. A commonly used method to identify SSCs by their cell surface phenotype is fluorescent-activated cell sorting (FACS) in combination with SSC transplantation. The first results of this approach were reported by Shinohara's group, who found that SSCs were enriched for β 1 -integrin (CD29) and α 6 -integrin (CD49f) but did not express α v -integrin (CD51).
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During subsequent years, more markers were identified. SSCs are positive for thymus cell antigen 1 (THY1 or CD90), CD9, glial cell line derived neurotropic factor (GDNF) family receptor α 1 (GFRα1), and E-cadherin, 28-31 and negative for major histocompatibility complex class I, C-Kit, and CD45.
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Although it is possible to highly enrich cell populations for SSCs (100-to 200-fold) using combinations of positive and negative markers, a pure SSC suspension has not been obtained so far. Apart from FACS, which is limited to the study of surface markers, other techniques are available to identify both cytoplasmic and nuclear SSC markers. Expression of green fluorescent protein (GFP) under the promoter of a candidate SSC gene is such a tool in mouse models. For example, octamer-binding transcription factor (OCT) 4-GFP mice enabled FACS-based isolation and transplantation of OCT4-expressing germ cells from a heterogeneous testis cell suspension. 21 Cells expressing OCT4 (GFP 
Specialized Niches for Spermatogonial Stem Cells
Spermatogonial stem cells can develop in three different ways: They can renew themselves, they can differentiate, or they can go into apoptosis. The mechanism determining which pathway will be followed is the subject of a great deal of investigation. The discovery in 2000 of the stem cell niche in Drosophila has accelerated the study of this regulatory system.
49
Niches are specialized microenvironments regulating tissue homeostasis by controlling stem cell self-renewal and differentiation. The SSC niche in the mammalian testis is located on the basal membrane of the seminiferous tubules and comprises Sertoli cells, peritubular myoid cells, and extracellular matrix components. Each niche houses one stem cell that is connected to the basement membrane through adhesion molecules (integrins). The fate of the stem cells is regulated by paracrine factors secreted by the niche. A key regulator of SSC self-renewal is glial cell linederived neurotrophic factor (GDNF), which is secreted by Sertoli cells and acts on A s , A pr , and A al spermatogonia through the RET/GFRα1 receptor complex (►Fig. 4).
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Sertoli cells are polarized columnar epithelial cells dividing the seminiferous tubule into a basal and an adlumenal compartment. The basal compartment comprises mainly spermatogonia, whereas the adlumenal compartment houses the more advanced germ cells. The two compartments are separated by tight junctions between Sertoli cells, the socalled blood-testis barrier (BTB). Germ cells have to cross the BTB during germ cell differentiation. The opening of the BTB regulates germ cell development by permitting the passage of preleptotene and leptotene spermatocytes. In this way, the differentiation process from leptotene spermatocytes up to mature sperm is separated from the systemic circulation. As such, Sertoli cells can supply developing germ cells with the necessary nutrients and establish an immune-privileged environment for haploid germ cells.
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Only recently, the influence of peritubular myoid cells on germ cell regulation was revealed. Because colonystimulating factor 1 expression was detected in Leydig and peritubular myoid cells, and its receptor was highly enriched in THY1 þ cells, a role on SSC maintenance was suggested.
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Not every germ cell located at the basal membrane is a SSC. Stem cell niches are not distributed randomly along the tubule but are thought to be localized in areas near the vasculature, implying a regulatory function for specific factors produced by the vascular endothelial cells.
52,53
The cell density in the seminiferous tubules is kept constant by density-dependent degeneration of differentiating spermatogonia. 54 Because of these observations, it was suggested that there is no need for a precise regulatory mechanism to maintain the number of the stem cells in the normal testis. However, when the seminiferous epithelium is depleted by cytotoxic agents or irradiation, restoration of spermatogenesis must occur from stem cells. SSCs are less sensitive than differentiating spermatogonia but can still be lost. It was observed that, in this situation, the percentage of A pr daughter cells was much lower than in the normal testis, which indicates that stem cells prefer self-renewal to differentiation.
55,56
Spermatogonial Stem Cell Culture
In a first attempt to maintain SSCs in vitro, testicular cells were cultured on embryonic fibroblasts in a medium containing fetal bovine serum. 57 The efficacy of SSC culture could be improved by enriching the cell suspension for SSCs or by using pup testicular cells. 58 The addition of GDNF to the culture increased SSC self-renewal 34 and was a great step forward in the establishment of long-term mouse SSC culture systems. 
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The debate on the plasticity of SSCs is still ongoing and indicates a need for further characterization of the testisderived cells before we may have a thorough understanding of their pluripotent potential.
Fertility Preservation and Restoration
About 1 in every 600 children develops cancer before the age of 15 years. Thanks to the remarkable progress that has been made in the treatment of cancer in infants and children, today >80% of them can be cured. It has been estimated that, by now, 1 in 250 adults in the age group of 20 to 30 years is a childhood cancer survivor. 76, 77 Besides cancer, other diseases requiring gonadotoxic treatments (e.g., sickle cell disease) or genetic diseases (e.g., Klinefelter syndrome, AZF deletions) may lead to spermatogonial stem cell loss. 78, 79 It is unquestionable that the prevention of sterility needs special attention in both oncology and reproductive medicine. The inability to father his genetically own children can have a significant impact on the psychological well-being of the patient in later adulthood. Whereas adult patients can be offered sperm banking before SSC loss, no such option exists to preserve the fertility in prepubertal boys. The cryopreservation of spermatogonial stem cells before gonadotoxic therapy followed by autologous intratesticular transplantation of these stem cells after cure is possibly the only option (►Fig. 5).
Cryopreservation of Stem Cells
To safeguard the reproductive potential of young cancer patients, cryopreservation of testicular tissue containing SSCs is preferred above cryopreservation of SSC suspensions. Indeed, the presence of the extracellular matrix and supporting cells is critical to germ cell survival and germ cell function. 80 Any cryopreservation protocol should thus aim at preserving both the stem cells and their niche cells. Undoubtedly, cryopreservation of testicular tissue is a challenging task. The complexity of the tissue architecture demands optimal conditions for each cellular type. Controlled slow freezing with dimethyl sulphoxide is routinely used to cryopreserve immature testicular tissue. [81] [82] [83] [84] In rodents, controlled slow freezing of prepubertal testicular tissue fragments has already led to the birth of healthy offspring. 85 Two teams have published freezing protocols for human testicular tissue using controlled rate freezing. Kvist et al reported the cryopreservation of testicular tissue in boys with cryptorchidism. 86 Later, Keros et al proposed a protocol for prepubertal testicular tissue. 87 Nevertheless, the drawback of controlled slow freezing is the need for expensive computerized equipment. Moreover, this freezing process consumes a lot of time and resources. Therefore, uncontrolled slow freezing has been explored. Like controlled freezing, uncontrolled freezing of prepubertal testicular tissue has been successfully used in different animal species, and it has been fully validated in mice as a means to preserve reproductive potential.
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Recently, in piglets and mice, vitrification was shown to yield similar results compared with slow freezing. [92] [93] [94] Because both uncontrolled freezing and vitrification are inexpensive, convenient, and fast executable protocols, these methods might be considered for human testicular tissue too.
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Spermatogonial Stem Cell Transplantation
The technique of spermatogonial stem cell transplantation was first reported by Brinster and Zimmermann in 1994. It involves the introduction of a germ cell suspension from a fertile donor testis into the seminiferous tubules of an infertile recipient mouse. 18 Transplanted spermatogonial stem cells were able to relocate onto the basement membrane and colonize the tubules during the first month after transplantation. From that moment on, SSCs started to proliferate and initiated spermatogenesis. The first meiotic germ cells appear after 1 month, and their number gradually increases thereafter. 96 It has been shown that the recipient mice could reproduce in vivo after transplantation and produce transgenic offspring. 19 Similar experiments were performed using SSCs that had been frozen and thawed. 97 Shortly after, this technology was performed in other mammalian species including primates. [98] [99] [100] [101] [102] Even the transplantation between different species with close phylogeny was proven successful. 103, 104 These encouraging results, especially those from primate studies, suggest a possibility of banking and subsequently transplanting human spermatogonial stem cells to prevent sterility caused by SSC loss. Before this application can be introduced in a clinical setting, it is important to evaluate the efficiency and the safety of the procedure. In the mouse, it was shown that sperm cells obtained after spermatogonial stem cell transplantation were able to fertilize and produce normal embryos after assisted reproduction, although litter sizes were smaller compared with normal fertile control mice. 105 A detailed analysis of the motility kinematics and concentrations of spermatozoa showed a lower sperm concentration Figure 5 Spermatogonial stem cell transplantation as a method for fertility restoration. Testicular tissue is removed and cryopreserved before the onset of the cancer treatment. After the patient has been cured, the thawed tissue can be transplanted into the remaining testis. When the boy reaches puberty, spermatogenesis may be established.
and sperm motility after transplantation. 106 In contrast, when donor and recipient were genetically related, the offspring showed normal genetic and epigenetic characteristics for most of the investigated modifications (►Figs. 6 and 7). [107] [108] [109] Only histone 4 lysines 5 and 8 acetylation, which is important in spermatids for the histone-to-protamine exchange, was impaired in spermatogonia and spermatocytes. The function of H4K5ac and H4K8ac in these cell types still has to be explored.
Testicular Tissue Grafting
Testicular tissue grafting has been suggested as an alternative to SSC transplantation. Testis tissue has been grafted under the back skin, in the scrotum, or in the testis. Mature spermatozoa could be obtained from ectopic grafts, 110 and progeny were born using intracytoplasmic sperm injection. 111 Full spermatogenesis was obtained in grafts using immature testis tissue from different species. 110,112-114 Ectopic grafting was also performed using human testicular tissue. The first reports using adult testicular tissue showed only limited spermatogonial survival, with most of the tubules completely regressed. 115, 116 Using prepubertal and neonatal tissue, spermatogonial survival 91 and differentiation up to primary spermatocytes 117 were reported in ectopic grafts. In an attempt to improve the results after grafting, immature testicular tissue was placed in the peritoneal bursa inside the scrotum. Long-term survival of spermatogonia and differentiation up to pachytene spermatocytes was observed.
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Intratesticular tissue transplantation was first reported in 2002. Sperm was produced after grafting cryopreserved immature testicular tissue from mice and rabbits into the testicular parenchyma. Progeny were born when rabbit sperm from the xenograft was used for microinsemination. 119 A comparison of intratesticular grafting and SSC transplantation (SSCT) in a mouse model showed a better reestablishment of spermatogenesis after grafting. Whereas some epigenetic modifications were found to be altered after SSCT, this was not the case after grafting.
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Cryopreservation of the grafts did not adversely affect the colonization efficiency and restoration of spermatogenesis. 120 Although intratesticular grafting seems to be more efficient, it can only be offered to patients with nonmalignant diseases or nonmetastasizing tumors.
Removal of Contaminating Malignant Cells
Many pediatric malignancies are capable of metastasizing through the blood, causing a potential risk of contamination of the collected testicular tissue. The transplantation of as few as 20 leukemic cells could cause malignant recurrence in rats. 121 In the human, the threshold number of malignant cells able to cause malignant relapse when transplanted to the testis is unknown. Therefore, it is of utmost importance to detect even the slightest contamination of the testicular tissue. In the case of contamination, the isolation of SSCs from malignant cells before transplantation is necessary. Apart from ours, another research group studied the use of magnetic-activated cell sorting and/or FACS for depleting cancer cells from mouse and human testicular cell suspensions. However, both reported insufficient depletion.
122-124
Also cell selection by selective matrix adhesion was not efficient enough. 
Concluding Thoughts
Banking and transplantation of SSCs may become a promising method to preserve the fertility of prepubertal patients. According to recent discoveries, the potential of SSCs to become pluripotent or to transdifferentiate into other cell types is interesting and may create an additional role for SSCs as a source for stem cell therapy. Nevertheless, the methods established in mice still need to be tested and adapted to human applications. 
